Our facility is currently reviewing a vasopressor extravasation case and one of our recommendations/objectives is to survey national practice for assessment of the PIV site with non-chemotherapeutic agents, i.e. vasopressors, infusing in the ICU and our cardiac unit. Here are the questions:
1. How often does a PIV site need to be assessed in this situation?
2. Is a blood return check/documentation part of the assessment?
3. Does anyone have a policy that covers this type of infusion/documentation (we have a recently created policy, but we may need to make changes) and, if you do have a policy, would you be willing to share the policy?
Thank you for your responses,